These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6932868)

  • 1. The effect of thioridazine on prolactin levels in acutely schizophrenic patients: challenge-dose and steady-state levels.
    Johnson GF; Hunt GE
    Aust N Z J Psychiatry; 1980 Jun; 14(2):127-31. PubMed ID: 6932868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and red cell levels of thioridazine and clinical response in schizophrenia.
    Smith RC; Baumgartner R; Ravichandran GK; Shvartsburd A; Schoolar JC; Allen P; Johnson R
    Psychiatry Res; 1984 Aug; 12(4):287-96. PubMed ID: 6594712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics.
    Vital-Herne J; Gerbino L; Kay SR; Katz IR; Opler LA
    J Clin Psychiatry; 1986 Jul; 47(7):375-9. PubMed ID: 2873133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone-induced increase in serum prolactin is correlated with positive symptom improvement in chronic schizophrenia.
    Zhang XY; Zhou DF; Yuan CL; Zhang PY; Wu GY; Shen YC
    Psychiatry Res; 2002 Apr; 109(3):297-302. PubMed ID: 11959366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motility, Parkinsonism, and prolactin with thiothixene and thioridazine.
    Crowley TJ; Hydinger-Macdonald M
    Arch Gen Psychiatry; 1981 Jun; 38(6):668-75. PubMed ID: 7247630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol in schizophrenia. Clinical, metabolic, and pharmacological findings.
    Hanssen T; Heyden T; Sundberg I; Alfredsson G; Nybäck H; Wetterberg L
    Arch Gen Psychiatry; 1980 Jun; 37(6):685-90. PubMed ID: 7387339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red blood cell and plasma levels of thioridazine and mesoridazine in schizophrenic patients.
    Shvartsburd A; Nwokeafor V; Smith RC
    Psychopharmacology (Berl); 1984; 82(1-2):55-61. PubMed ID: 6420831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia.
    McCreadie RG; Todd N; Livingston M; Eccleston D; Watt JA; Herrington RN; Tait D; Crocket G; Mitchell MJ; Huitfeldt B
    Acta Psychiatr Scand Suppl; 1990; 358():136-7. PubMed ID: 1978473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine tests during treatment with neuroleptic drugs I. Plasma prolactin response to haloperidol challenge.
    Kolakowska T; Braddock L; Wiles D; Franklin M; Gelder M
    Br J Psychiatry; 1981 Nov; 139():400-4. PubMed ID: 6120731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of neuroleptics on serum prolactin in schizophrenic patients.
    Meltzer HY; Fang VS
    Arch Gen Psychiatry; 1976 Mar; 33(3):279-86. PubMed ID: 1259521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin responses to neuroleptics in normal and schizophrenic subjects.
    Gruen PH; Sachar EJ; Langer G; Altman N; Leifer M; Frantz A; Halpern FS
    Arch Gen Psychiatry; 1978 Jan; 35(1):108-16. PubMed ID: 23087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine antagonism by thioridazine in schizophrenia.
    Meltzer HY; Sachar EJ; Frantz AG
    Biol Psychiatry; 1975 Feb; 10(1):53-7. PubMed ID: 1120175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of serum neuroleptic and prolactin concentrations during short- and long-term treatment of schizophrenic patients.
    Rao ML; Brown WA
    Psychopharmacology (Berl); 1987; 93(2):237-42. PubMed ID: 2892222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum prolactin response to chlorpromazine and psychopathology in schizophrenics: implications for the dopamine hypothesis.
    Meltzer HY; Busch D
    Psychiatry Res; 1983 Aug; 9(4):285-99. PubMed ID: 6580661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood levels of haloperidol and thioridazine during maintenance neuroleptic treatment of schizophrenic outpatients.
    Shvartsburd A; Sajadi C; Morton V; Mirabi M; Gordon J; Smith RC
    J Clin Psychopharmacol; 1984 Aug; 4(4):194-8. PubMed ID: 6470190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum prolactin as a correlate of clinical response to haloperidol.
    Van Putten T; Marder SR; Mintz J
    J Clin Psychopharmacol; 1991 Dec; 11(6):357-61. PubMed ID: 1770154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thioridazine improves affective symptoms in schizophrenic patients.
    Dufresne RL; Valentino D; Kass DJ
    Psychopharmacol Bull; 1993; 29(2):249-55. PubMed ID: 8290673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind comparison of trebenzomine and thioridazine in the treatment of schizophrenia.
    Georgotas A; Gerbino L; Jordan B; McCarthy M; Gershon S; Kleinberg D; Lautin A; Stanley M; Rotrosen J
    Psychopharmacology (Berl); 1981; 73(3):292-4. PubMed ID: 6113618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma fluphenazine and prolactin levels in schizophrenic patients during treatment with low and high doses of fluphenazine enanthate.
    Wiles D; Franklin M; Dencker SJ; Johansson R; Lundin L; Malm U
    Psychopharmacology (Berl); 1980; 71(2):131-6. PubMed ID: 6777812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum prolactin and clinical state during neuroleptic treatment and withdrawal.
    Laughren TP; Brown WA; Williams BW
    Am J Psychiatry; 1979 Jan; 136(1):108-10. PubMed ID: 758812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.